Skip to main content
SpringerLink
Log in

Long-term comparison of balloon angioplasty with provisional stenting versus routine stenting in patients with non-ST-elevation acute coronary syndrome

  • Original article
  • Published:
Netherlands Heart Journal Aims and scope Submit manuscript

Abstract

Background. In patients with unstable angina or non-ST-elevation acute coronary syndrome (NSTE-ACS) who are eligible for PCI, routine stenting is the recommended treatment strategy, based on the opinion of experts. Provisional stenting may provide a viable alternative by retaining the early benefits of stenting without its potential late hazards.

Method. Patients with NSTE-ACS were randomised to provisional or routine stenting after coronary angiography. Patients were followed for up to ten years. The occurrence of major adverse cardiac events (MACE) was recorded.

Results. 237 consecutive patients with NSTE-ACS were randomly assigned to routine stenting (n=116) or provisional stenting (n=121). No difference in the incidence of MACE at 30 days was observed. At six months, angiographic restenosis was lower in the routine stenting group (41 vs. 20%, p=0.02), paralleled by more MACE in the provisional stenting group at one year (40.5 vs. 27.6%, p=0.036). At complete follow-up the difference in MACE was not significant (61.2 vs. 50%, p=0.084) because of relatively more target lesion revascularisations in the routine stent group. There was no difference in the incidence of very late stent thrombosis (1.7 vs. 3.4%, p=0.439). The only independent predictor of MACE was β-blocker use (RR 0.62 [0.431; 0.892] p=0.010).

Conclusion. In selective patients with NSTE-ACS, routine stenting was more beneficial than provisional stenting for a period of up to five years, driven by a reduction in repeat revascularisation procedures. After this period, the benefit was no longer significant. Beta-blocker use was the only independent predictor of MACE throughout the complete follow-up period. (Neth Heart J 2010;18:307-313.)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, et al. A comparison of balloon-expandable- stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489-95.

    Google Scholar 

  2. Kiemeneij F, Serruys PW, Macaya C, Rutsch W, Heyndrickx G, Albertsson P, et al Continued benefit of coronary stenting versus balloon angioplasty: Five-year clinical follow-up of Benestent-1 trial. J Am Coll Cardiol. 2001;37:1598-603.

    Google Scholar 

  3. Betriu A, Masotti M, Serra A, Alonso J, Fernández-Avilés F, Gimeno F, et al. Randomized comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START) A four-year follow-up. J Am Coll Cardiol. 1999;34:1498-506.

    Google Scholar 

  4. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496-501.

    Google Scholar 

  5. Vernon Anderson H, Carabello BA. Provisional versus routine stenting: routine stenting is here to stay. Circulation. 2000;102:2910-4.

    Google Scholar 

  6. Vernon Anderson H, Shaw RE, Brindis RG, Hewitt K, Krone RJ, Block PC, et al. A contemporary overview of percutaneous coronary interventions. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). J Am Coll Cardiol. 2002;39:1096-103.

    Google Scholar 

  7. Silber S, Albertsson P, Avilés FF, Camici PG, Colombo A, Hamm C, et al. Guidelines for percutaneous coronary interventions The Task Force for Percutaneous Coronary Interventions Of the European society of Cardiology. Eur Heart J. 2005;8;804-47.

    Google Scholar 

  8. Mueller Ch, Buettner HJ, Hodgson JM, Marsch S, Perruchoud AP, Roskamm H, et al. Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with early invasive strategy in 1042 consecutive patients. Circulation. 2002;105;1412-5.

  9. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med. 2000;343:1139-47.

    Google Scholar 

  10. Rioufol G, Finet G, Ginon I, André-Fouët X, Rossi R, Vialle E, et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome. A three-vessel intravascular ultrasound study. Circulation. 2002;106:804-8.

    Google Scholar 

  11. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the unstable plaque. Prog Cardiovasc Dis. 2002;44:349-56.

    Google Scholar 

  12. Okura H, Taguchi H, Kubo T, Toda I, Yoshiyama M, Yoshikawa J, et al. Impact of arterial remodelling and plaque rupture on target and non-target lesion revascularisation after stent implantation in patients with acute coronary syndrome: an intravascular ultrasound study. Heart. 2007;93:1219-25.

    Google Scholar 

  13. Nakamura M, Yock PG, Bonneau HN, Kitamura K, Aizawa T, Tamai H, et al. Impact of peri-stent remodelling on restenosis: a volumetric intravascular ultrasound study. Circulation. 2001;103;2130-2.

    Google Scholar 

  14. Mauri L, Hsieh W-H, Massaro J, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356:1020-9.

    Google Scholar 

  15. Marzocchi A, Piovaccari G, Marozzini C, Ortolani P, Palmerini T, Branzi A, et al. Results of coronary stenting for unstable versus stable angina pectoris. Am J Cardiol. 1997;79:1314-8.

    Google Scholar 

  16. Lincoff AM, Califf RM, Moliterno DJ, Ellis SG, Ducas J, Kramer JH, et al. Complementary clinical benefits of coronary artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. N Engl J Med. 1999;341:319-27.

    Google Scholar 

  17. The EPISTENT Investigators. Randomised placebo-controlled and balloon angioplasty-controlled trials to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade. Lancet. 1998;352:87-92.

  18. Al Suwaidi J, Holmes DR, Salam AM, Lennon R, Berger PB. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: Meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty. Am Heart J. 2004;147:815-22.

    Google Scholar 

  19. Kandzari DE, Tuttle RH, Zidar JP, Jollis JG. Comparison of long-term (seven year) outcomes among patients undergoing percutaneous coronary revascularization with versus without stenting. Am J Cardiol. 2006; 97:1467-72.

    Google Scholar 

  20. Cutlip DE, Chhabra AG, Baim DS, Chauhan MS, Marulkar S, Massaro J, et al. Beyond Restenosis. Five-year clinical outcomes from second-generation coronary stent trials. Circulation. 2004;110:1226-30.

    Google Scholar 

  21. Suryapranata H, De Luca G, van ’t Hof AWJ, Ottervanger JP, Hoorntje JCA, Dambrink JHE, et al. Is routine stenting for acute myocardial infarction superior to balloon angioplasty? A randomised comparison in a large cohort of unselected patients. Heart. 2005;91:641-5.

    Google Scholar 

  22. Jackson JD, Muhlestein JB, Bunch TJ, Bair TL, Horne BD, Madsen TE, et al; Intermountain Heart Collaborative Study Group. β-Blockers reduce the incidence of clinical restenosis: Prospective study of 4840 patients undergoing percutaneous coronary revascularization. Am Heart J. 2003;145:875-81.

    Google Scholar 

  23. The task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European society of cardiology. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007;28:1598-660.

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Isala Klinieken, PO Box 10400, 8000, GK, Zwolle, the Netherlands

    D. A. A. M. Schellings

  2. www.bsl.nl/shop/

    D. A. A. M. Schellings

Authors
  1. D. A. A. M. Schellings
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. C. A. Hoorntje
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. J. de Boer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. W. J. van ’t Hof
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Suryapranata
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. A. A. M. Schellings.

Additional information

Department of Cardiology, Isala Klinieken, Zwolle, the Netherlands

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schellings, D.A.A.M., Hoorntje, J.C.A., de Boer, M.J. et al. Long-term comparison of balloon angioplasty with provisional stenting versus routine stenting in patients with non-ST-elevation acute coronary syndrome . NHJL 18, 307–313 (2010). https://doi.org/10.1007/BF03091781

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03091781

Search

Navigation